A Phase II Efficacy and Safety, Open-Label, Multicenter...

  • Main
  • 2016 / 2
  • A Phase II Efficacy and Safety, Open-Label, Multicenter...
Clinical Colorectal Cancer 2016 / 2

A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer

Segal, Neil H., Gada, Purvi, Senzer, Neil, Gargano, Michele A., Patchen, Myra L., Saltz, Leonard B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2016.02.013
Date:
February, 2016
File:
PDF, 276 KB
english, 2016
Conversion to is in progress
Conversion to is failed